Publications

Joint associations of device-measured step count and sleep duration with incident major adverse cardiovascular events: prospective analysis of the UK Biobank.

Yun J. et al, (2026), EClinicalMedicine, 92

Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.

Cholesterol Treatment Trialists' (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk . and Cholesterol Treatment Trialists' (CTT) Collaboration ., (2026), Lancet (London, England)

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2026), The Lancet. Infectious diseases, 26, 34 - 45

Active Monitoring for AtriaL FIbrillation (AMALFI): Rationale, protocol, and pilot for a pragmatic, randomized, controlled trial of remote screening for asymptomatic atrial fibrillation.

Wijesurendra R. et al, (2025), American heart journal, 290, 310 - 324

Daily steps are a predictor of, but perhaps not a risk factor for Parkinson's disease: findings from the UK Biobank.

Acquah A. et al, (2025), NPJ Parkinson's disease, 11

Remote Screening for Asymptomatic Atrial Fibrillation: The AMALFI Randomized Clinical Trial.

Wijesurendra R. et al, (2025), JAMA, 334, 1349 - 1357

Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2025), The Lancet. Infectious diseases, 25, 1000 - 1010

Association of Daily Steps with Incident Nonalcoholic Fatty Liver Disease: Evidence from the UK Biobank Cohort.

Fulda ES. et al, (2025), Medicine and science in sports and exercise, 57, 1905 - 1913

Joint associations of device-measured physical activity and sleep duration with incident major adverse cardiovascular events: prospective analysis of the UK Biobank

Brocklebank L. et al, (2025)

Predictive performance of wearable sensors for mortality risk in older adults: a model development and validation study.

Harper C. et al, (2025)

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2025), EClinicalMedicine, 81

Daily Step Counts, Step Intensity, And Mortality Risk Among U.s. Adults

Shreves AH. et al, (2025), MEDICINE & SCIENCE IN SPORTS & EXERCISE, 57, 280 - 281

Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.

Sydes MR. et al, (2024), Contemporary clinical trials, 141

Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England.

Pessoa-Amorim G. et al, (2024), Trials, 25

92 The added value of deep learning to submaximal exercise electrocardiogram for the 10-year prediction of major adverse cardiovascular and cerebrovascular events

Sturge A. et al, (2024), Cardiac rhythm management, A95.2 - A96

36 The added value of device measured physical activity to the prediction of incident cardiovascular disease

Sturge A. et al, (2024), Acute coronary syndromes & interventional cardiology, A40 - A41

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk . and Cholesterol Treatment Trialists’ (CTT) Collaboration ., (2024), The lancet. Diabetes & endocrinology, 12, 306 - 319

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2024), The Lancet. Child & adolescent health, 8, 190 - 200

Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson’s Disease: findings from the UK Biobank

Acquah A. et al, (2024)

Association of daily steps with incident non-alcoholic fatty liver disease: Evidence from the UK Biobank cohort

Fulda E. et al, (2024)

Cookies on this website

Search results (42)